Naoual Bakrin

3.4k total citations · 1 hit paper
85 papers, 1.9k citations indexed

About

Naoual Bakrin is a scholar working on Surgery, Reproductive Medicine and Emergency Medicine. According to data from OpenAlex, Naoual Bakrin has authored 85 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Surgery, 49 papers in Reproductive Medicine and 44 papers in Emergency Medicine. Recurrent topics in Naoual Bakrin's work include Intraperitoneal and Appendiceal Malignancies (78 papers), Ovarian cancer diagnosis and treatment (49 papers) and Appendicitis Diagnosis and Management (44 papers). Naoual Bakrin is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (78 papers), Ovarian cancer diagnosis and treatment (49 papers) and Appendicitis Diagnosis and Management (44 papers). Naoual Bakrin collaborates with scholars based in France, Saudi Arabia and India. Naoual Bakrin's co-authors include Olivier Gléhen, Guillaume Passot, Laurent Villeneuve, Mohammad Alyami, Vahan Képénékian, Eddy Cotte, Nathalie Laplace, Martin Hübner, Frédéric Mercier and Fabian Grass and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and The Lancet Oncology.

In The Last Decade

Naoual Bakrin

83 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications

2019 215 citations Mohammad Alyami, Martin Hübner et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Naoual Bakrin

Since Specialization

Citations

This map shows the geographic impact of Naoual Bakrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoual Bakrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoual Bakrin more than expected).

Fields of papers citing papers by Naoual Bakrin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoual Bakrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoual Bakrin. The network helps show where Naoual Bakrin may publish in the future.

Co-authorship network of co-authors of Naoual Bakrin

This figure shows the co-authorship network connecting the top 25 collaborators of Naoual Bakrin. A scholar is included among the top collaborators of Naoual Bakrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoual Bakrin. Naoual Bakrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Generation of continuous production of polymeric nanoparticles via microfluidics for aerosolised localised drug delivery 2025 ·International Journal of Pharmaceutics ·(unknown), Giulia Guerriero, Naoual Bakrin, Jérémie Pourchez, (unknown), Lara Leclerc, (unknown), (unknown), Katrien Remaut, David Kryza, Giovanna Lollo	0
2	Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Epithelial Ovarian Cancer: A GRADE Approach for Evidence Evaluation and Recommendation 2025 ·Journal of Surgical Oncology ·Donal J. Brennan, (unknown), Michela Cinquini, Aditi Bhatt, (unknown), (unknown), Andreas Brandl, Edward A. Levine, Thanh H. Dellinger, Naoual Bakrin, (unknown), (unknown), Dario Baratti, Marcello Guagliò, Shigeki Kusamura, Marcello Deraco	1
3	Intraperitoneal Nivolumab after Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion Cohort 2024 ·Clinical Cancer Research ·Pauline Corbaux, Gilles Freyer, Olivier Gléhen, Benoît You, Naoual Bakrin, (unknown), (unknown), Christophe Sajous, Max Piffoux, Julien Péron, (unknown), Léa Payen, Vahan Képénékian	3
4	Number of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatments is Associated With Longer Survival 2024 ·Annals of Surgery ·(unknown), Naoual Bakrin, (unknown), Laurent Villeneuve, (unknown), (unknown), Olivier Gléhen, Vahan Képénékian	3
5	Descriptive review of current practices and prognostic factors in patients with ovarian cancer treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC): a multicentric, retrospective, cohort of 234 patients 2023 ·Frontiers in Oncology ·Amaniel Kefleyesus, Aditi Bhatt, (unknown), V. M. Khomyakov, Martin Hübner, Marc A. Reymond, René Thieme, Olivia Sgarbură, Wouter Willaert, Wim Ceelen, Andrea Di Giorgio, Giuseppe Vizzielli, Olivier Gléhen, Manuela Robella, Naoual Bakrin	3
6	The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Methodology 2023 ·Annals of Surgical Oncology ·Shigeki Kusamura, Aditi Bhatt, Martin Hübner, Laurent Villeneuve, (unknown), Naoual Bakrin, Kurt Van der Speeten, Olivier Gléhen	10
7	Localized chemotherapy approaches and advanced drug delivery strategies: a step forward in the treatment of peritoneal carcinomatosis from ovarian cancer 2023 ·Frontiers in Oncology ·(unknown), Serena Zilio, (unknown), Naoual Bakrin, David Kryza, Giovanna Lollo	8
8	Platinum resistant recurrence and early recurrence in a multi-centre cohort of patients undergoing interval cytoreductive surgery for advanced epithelial ovarian cancer 2022 ·Frontiers in Oncology ·Aditi Bhatt, Snita Sinukumar, Vahan Képénékian, Praveen Kammar, Sanket Mehta, (unknown), (unknown), Naoual Bakrin, Olivier Gléhen	1
9	Technique of pressurized intrathoracic aerosol chemotherapy (PITAC) for malignant pleural effusion 2020 ·PubMed ·(unknown), Jean‐Michel Maury, Naoual Bakrin, François Tronc	5
10	Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications 2020 ·European Journal of Surgical Oncology ·Aditi Bhatt, Naoual Bakrin, Praveen Kammar, Sanket Mehta, Snita Sinukumar, (unknown), (unknown), (unknown), (unknown), Vahan Képénékian, Nazim Benzerdjeb, Olivier Gléhen	11
11	MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma 2019 ·PubMed ·Olivia Sgarbură, Sophie Gourgou, Diégo Tosi, Naoual Bakrin, (unknown), (unknown), Hélène de Forges, Marc Pocard, François Quénet	18
12	Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications breakdown → 2019 ·The Lancet Oncology ·Mohammad Alyami, Martin Hübner, Fabian Grass, Naoual Bakrin, Laurent Villeneuve, Nathalie Laplace, Guillaume Passot, Olivier Gléhen, Vahan Képénékian	215
13	PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer 2018 ·PubMed ·Naoual Bakrin, Clemens Tempfer, Giovanni Scambia, Michele De Simone, Boris Gabriel, Eva‐Maria Grischke, Beate Rau, (unknown)	31
14	Occupational exposure to platinum drugs during intraperitoneal chemotherapy. Biomonitoring and surface contamination 2018 ·Toxicology Letters ·Sophie Ndaw, (unknown), (unknown), (unknown), (unknown), (unknown), Alain Robert, Naoual Bakrin	36
15	Colorectal resection with pelvic peritoneal carcinomatosis en-bloc resection in a male patient (with video) 2016 ·Journal of Visceral Surgery ·(unknown), Naoual Bakrin, Olivier Gléhen, Guillaume Passot	1
16	Glisson capsulectomy for extensive superficial liver involvement in peritoneal carcinomatosis (with video) 2015 ·Journal of Visceral Surgery ·(unknown), Guillaume Passot, Olivier Gléhen, Naoual Bakrin	6
17	Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer 2014 ·Journal of Visceral Surgery ·Naoual Bakrin, Jean‐Marc Classe, Christophe Pomel, Sébastien Gouy, G. Chêne, Olivier Gléhen	44
18	Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients 2012 ·Annals of Surgical Oncology ·Naoual Bakrin, Eddy Cotte, François Golfier, F.N. Gilly, Gilles Freyer, (unknown), Olivier Gléhen, Jean-Marc Béréder	84
19	Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Recurrent Endometrial Carcinoma Confined to the Peritoneal Cavity 2010 ·International Journal of Gynecological Cancer ·Naoual Bakrin, Eddy Cotte, (unknown), D. Raudrant, Sylvie Isaac, Faheez Mohamed, François-Noël Gilly, Olivier Gléhen	20
20	Appraisal of peritoneal cavity’s capacity in order to assess the pharmacology of liquid chemotherapy solution in hyperthermic intraperitoneal chemotherapy 2009 ·Surgical and Radiologic Anatomy ·(unknown), Eddy Cotte, Olivier Gléhen, François Cotton, Naoual Bakrin	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact